Tvardi Therapeutics (TVRD) Misses Q3 EPS by 59c

Tvardi Therapeutics (NASDAQ: TVRD) reported Q3 EPS of ($0.59).

For earnings history and earnings-related data on Tvardi Therapeutics (TVRD) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c